# FDA Inspection 1166545 - Baxalta US Inc. - April 07, 2022

Source: https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/0a393ccc-bf48-4160-8b4c-45d96b6b62fb
Source feed: FDA_Inspections

> FDA Inspection 1166545 for Baxalta US Inc. on April 07, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166545
- Company Name: Baxalta US Inc.
- Inspection Date: 2022-04-07
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1279237 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/95291689-7d92-4668-a518-7c2443655647)
- [FDA Inspection 1118072 - 2020-01-17](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/1e6d6d48-82cf-4812-9ae5-37c4ede74bed)
- [FDA Inspection 1038757 - 2018-01-19](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/67db9420-6ce8-4bd7-a8b9-1dfa5e54a11d)
- [FDA Inspection 972505 - 2016-03-10](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/30493d69-98cd-4a3b-b09d-f051d8ba77c3)
- [FDA Inspection 870344 - 2014-02-28](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/8c09b35e-857a-4441-b0d2-63d7c71a4aa6)

Company: https://www.keypedia.com/companies/baxalta-us-inc/dd00e45b-9175-4b17-82d5-b189a034a97f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d